CAP re-accredited as CME provider for physicians THE FACULTY of American Pathologists was resurveyed by the Accreditation Council for Continuing Medical Education and awarded Accreditation with Commendation for six years as a provider of continuing medical education for physicians. The prestigious designation means that the CAP provides exceeded standards established for accreditation http://www.tadacip.net/reviews.html . Education may be the cornerstone of CAP offerings, stated CAP President Gene N. Herbek, MD, FCAP. We are pleased with the ACCME's recognition as a premier CME supplier for pathology education to help equip pathologists for current and emerging roles in health care leading to better look after patients.
CCCB selects CLC bio’s enterprise platform for next generation sequence analysis After an intensive head-to-head evaluation against various competing solutions, the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute has selected CLC bio’s enterprise platform for next generation sequence analysis. The CCCB provides analytical support services for researchers and labs at the Dana-Farber Cancers Institute. Over the past 2 yrs the CCCB offers experienced a significant increase in the amount of researchers who are getting into high-throughput sequencing. How are we likely to support an increasing number of molecular biologists and clinicians who don’t possess their own bioinformatics resources? That’s really what started our evaluation and just why we ultimately chosen CLC bio, after viewing how easy it had been for users to do analyses and watch their data through CLC bio’s user-friendly interface , states Associate Director at the CCCB at the Dana-Farber Malignancy Institute, Mick Correll, and continues, CLC bio’s platform also provides flexible deployment opportunities.